YKP3089

Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Cenobamate Expanded Access Program (EAP)